Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

52.58
Delayed Data
As of Feb 12
 +0.40 / +0.77%
Today’s Change
45.45
Today|||52-Week Range
71.60
-11.24%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Operating ActivitiesNet Income / Starting Line5.3B4.1B1.8B--
 
 
 
 
Depreciation1.2B897.0M786.0M--
 
 
 
 
Total Other Cash Flow541.0M584.0M1.8B--
 
 
 
 
Funds From Operations7.0B5.6B4.3B--
 
 
 
 
Funds From/For Other Operating Expenses621.0M-658.0M788.0M--
 
 
 
 
Net Cash Flow - Operating Activities6.3B6.3B3.5B--
 
 
 
 
 
InvestingIncrease In Investments-2.6B-930.0M-1.2B--
 
 
 
 
Decrease In Investments1.2B2.7B1.5B--
 
 
 
 
Capital Expenditures-333.0M-491.0M-612.0M--
 
 
 
 
Net Assets From Acquisitions -688.0M-405.0M-622.0M--
 
 
 
 
Net Cash Flow Investing-2.4B879.0M-926.0M--
 
 
 
 
 
FinancingShort Term Borrowings1.0B-601.0M12.0M--
 
 
 
 
Long Term Borrowings14.6B0.000.00--
 
 
Long Term Debt Reduction0.000.000.00----
Net Proceeds Stock Sale0.00347.0M225.0M--
 
 
 
Common Preferred Redeemed0.00-320.0M-652.0M--
 
 
 
Common Dividends0.00-2.6B-2.7B--
 
 
 
Cash Dividends Paid - Total0.00-2.6B-2.7B--
 
 
 
Other Sources - Financing0.000.000.00----
Other Uses - Financing13.7B313.0M217.0M--
 
 
 
 
Net Cash Flow - Financing1.9B-3.4B-3.3B--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash16.0M-10.0M-577.0M--
 
 
 
 
 
Net Change In Cash5.9B3.7B-670.0M0.00